Status:
COMPLETED
The Effect of Milk Protein vs Blends of Milk and Plant Protein on Growth Markers in 7-8 Year Old Healthy Danish Children
Lead Sponsor:
University of Copenhagen
Collaborating Sponsors:
Arla Foods
University of Aarhus
Conditions:
Growth Acceleration
Growth; Stunting, Nutritional
Eligibility:
All Genders
7-8 years
Phase:
NA
Brief Summary
The purpose of PROGRO is to determine which combinations of milk and plant proteins are optimal to promote growth factors in children
Detailed Description
The main objective is to assess how different protein blends affect growth factors in children. There is evidence to support that milk protein increases growth in children in both high and low-income ...
Eligibility Criteria
Inclusion
- Age 7-8 years
- Healthy\*
- The child is willing to consume protein powder twice a day for 4 weeks
- The child is not a picky eater and so does not mind trying new foods and flavours
- The child speaks Danish in order to understand the study procedures
- The parents read and speak Danish in order to be properly informed about the study procedures
- Written informed consent has been obtained
- The principal investigator, who is blinded to study treatment, will perform a case-by-case medical evaluation of children with any signs of being unhealthy or having any illness or taking medication at the time of admission. If the conditions are considered to potentially affect protein metabolism or growth, the children will not be included. If a child is acutely ill at the scheduled time of study start, the child cannot be included. But the child may be included later when the acute illness has resolved
Exclusion
- The child drinks more than 350 ml of milk per day
- Known or suspected allergy, sensitization or intolerance to milk (protein or lactose), rapeseed or mustard
- Any acute illness\*
- Chronic illness or disease that may affect protein metabolism or growth\*
- Chronic intake of medicine that may affect protein metabolism or growth\*
- Concomitant participation in other studies involving dietary supplements or blood sampling
- Living in a household with another participating child
- The principal investigator, who is blinded to study treatment, will perform a case-by-case medical evaluation of children with any signs of being unhealthy or having any illness or taking medication at the time of admission. If the conditions are considered to potentially affect protein metabolism or growth, the children will not be included. If a child is acutely ill at the scheduled time of study start, the child cannot be included. But the child may be included later when the acute illness has resolved
Key Trial Info
Start Date :
January 18 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 18 2018
Estimated Enrollment :
129 Patients enrolled
Trial Details
Trial ID
NCT03384719
Start Date
January 18 2018
End Date
December 18 2018
Last Update
August 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Nutrition, Exercise and Sports
Copenhagen, Frederiksberg, Denmark, 1958